<p>新加坡，2026 年 1 月 7 日（环球新闻通讯社）——EUDA Health Holdings Limited（纳斯达克代码：EUDA）“EUDA” 或 “公司”，是一家总部位于新加坡的非侵入性医疗服务提供商，专注于新加坡、马来西亚和中国，今天宣布已与 Streeterville Capital, LLC（“Streeterville Capital”）签署了对其先前披露的认股权证协议的修订（“认股权证修订”）。</p>
<p><strong>原始认股权证交易背景</strong></p>
<p>如之前所述，2025 年 11 月 26 日，EUDA 与位于犹他州的有限责任公司 Streeterville Capital 签署了一项证券购买协议，发行了一份认股权证（“认股权证”），可行使购买多达 2,000,000 股新发行的 EUDA 普通股，购买总价为 100,000 美元。该认股权证于 2025 年 12 月 4 日发行。认股权证及其认股权证股份的要约和销售是根据 2025 年 12 月 4 日的招股说明书补充进行的，作为 2024 年 10 月 18 日提交给证券交易委员会的 F-3 表格注册声明（文件编号：333-282723）的一部分，并于 2024 年 11 月 4 日生效。认股权证可在发行之日起的九十（90）天内以现金行使（除非双方延长）（“现金行使期”）。在现金行使期结束后的两周内，Streeterville Capital 将自动被视为进行了 “无现金” 行使，且公司将需向 Streeterville Capital 发行每十（10）股未行使认股权证股份对应的一（1）股普通股，无需额外对价。</p>
<p><strong>修订条款摘要</strong></p>
<p>2025 年 12 月 16 日，EUDA 与 Streeterville Capital 签署了认股权证修订，内容包括（i）将认股权证的行使价格从每股 6.00 美元降低至每股 4.00 美元，以及（ii）将触发 “强制行使”（在认股权证中定义）所需的最低收盘价从 7.50 美元降低至 6.00 美元。认股权证的其他条款保持不变。</p>
<p><strong>关于 EUDA Health Holdings Limited</strong></p>
<p>EUDA Health Holdings Limited（纳斯达克代码：EUDA）是一家总部位于新加坡的领先非侵入性医疗服务提供商，专注于新加坡、马来西亚和中国。公司旨在成为非侵入性和预防性医疗领域的市场领导者，战略重点放在快速增长的长寿产业。我们的使命是满足超过 18 亿人不断变化的医疗需求，该地区正经历显著的人口结构变化，超过 30% 的人口迅速老龄化。通过提供创新、可及且基于科学的健康解决方案，EUDA 致力于引领区域医疗从反应性医疗转向以长寿为重点的主动护理。EUDA 还经营一家总部位于新加坡的物业管理业务。</p>
<p><strong>前瞻性声明</strong></p>
<p>本文件可能包含关于风险和不确定性的前瞻性声明。这些声明通常使用前瞻性词汇，例如 “估计”、“预测”、“期望”、“设想”、“预期”、“预测”、“计划”、“打算”、“相信”、“寻求”、“可能”、“将”、“应该”、“未来”、“提议” 及这些词或类似表达的变体（或这些词或表达的否定版本）。这些前瞻性声明并不保证未来的表现、状况或结果，并涉及许多已知和未知的风险、不确定性、假设和其他重要因素，其中许多超出了 EUDA 的控制范围，可能导致实际结果或结果与前瞻性声明中讨论的内容有实质性差异。您不应过于依赖仅适用于本文件发布之日的前瞻性声明。公司不承担更新或修订任何前瞻性声明的义务，无论是由于新信息、未来事件还是其他原因，法律要求的情况除外。</p>
<p>Christensen Advisory</p>
<p>Christian Arnell</p>
<p>电话：+ 852 9040 0621</p>
<p>电子邮件：christian.arnell@christensencomms.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeU1UTXhNU00zTXpRNE5UVTRJelV3TURFeU5EUXpPUT09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeU1UTXhNU00zTXpRNE5UVTRJelV3TURFeU5EUXpPUT09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/Y2Y1ZDZkMDMtZTM0Yy00YzhmLTgzZDQtODYwMmRjMTA5MTVlLTUwMDEyNDQzOS0yMDI2LTAxLTA3LWVu/tiny/EUDA-Health-Holdings-Ltd.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/Y2Y1ZDZkMDMtZTM0Yy00YzhmLTgzZDQtODYwMmRjMTA5MTVlLTUwMDEyNDQzOS0yMDI2LTAxLTA3LWVu/tiny/EUDA-Health-Holdings-Ltd.png"/></p>

EUDA

<p>EUDA Health Holdings Limited 已经修改了与 Streeterville Capital 的认股权证协议，将行使价格从每股 6.00 美元降低至 4.00 美元，并将强制行使的最低收盘价从 7.50 美元降低至 6.00 美元。原始认股权证于 2025 年 12 月 4 日发行，允许以 100,000 美元的价格购买最多 2,000,000 股。EUDA 专注于亚洲的非侵入性医疗保健，特别是在新加坡、马来西亚和中国，旨在成为预防医疗解决方案的领导者</p>

<p>SINGAPORE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that it has entered into an amendment (the “Warrant Amendment”) to its previously disclosed warrant agreement with Streeterville Capital, LLC (“Streeterville Capital”).</p>
<div class="lb-trans"><p>新加坡，2026 年 1 月 7 日（环球新闻通讯社）——EUDA Health Holdings Limited（纳斯达克代码：EUDA）“EUDA” 或 “公司”，是一家总部位于新加坡的非侵入性医疗服务提供商，专注于新加坡、马来西亚和中国，今天宣布已与 Streeterville Capital, LLC（“Streeterville Capital”）签署了对其先前披露的认股权证协议的修订（“认股权证修订”）。</p>
</div><p><strong>Background on the Original Warrant Transaction</strong></p>
<div class="lb-trans"><p><strong>原始认股权证交易背景</strong></p>
</div><p>As previously announced, on November 26, 2025, EUDA entered into a securities purchase agreement with Streeterville Capital, a Utah limited liability company, for the issuance of a warrant (the “Warrant”) exercisable into up to 2,000,000 newly issued ordinary shares of EUDA for an aggregate purchase price of US$100,000. The Warrant was issued on December 4, 2025. The offer and sale of the Warrant and the Warrant Shares were made pursuant to a prospectus supplement dated December 4, 2025, as part of a registration statement on Form F-3 (File No. 333-282723), which was filed with the Securities and Exchange Commission on October 18, 2024 and declared effective on November 4, 2024. The Warrant may be exercised for cash for ninety (90) days (unless extended by the parties) from the date of issuance (the “Cash Exercise Period”). At the end of two weeks after the Cash Exercise Period has expired, Streeterville Capital will automatically be deemed to have made a “cashless” exercise of the Warrant, and the Company will be required to issue to Streeterville Capital one (1) ordinary share for every ten (10) outstanding Warrant Shares for no additional consideration.</p>
<div class="lb-trans"><p>如之前所述，2025 年 11 月 26 日，EUDA 与位于犹他州的有限责任公司 Streeterville Capital 签署了一项证券购买协议，发行了一份认股权证（“认股权证”），可行使购买多达 2,000,000 股新发行的 EUDA 普通股，购买总价为 100,000 美元。该认股权证于 2025 年 12 月 4 日发行。认股权证及其认股权证股份的要约和销售是根据 2025 年 12 月 4 日的招股说明书补充进行的，作为 2024 年 10 月 18 日提交给证券交易委员会的 F-3 表格注册声明（文件编号：333-282723）的一部分，并于 2024 年 11 月 4 日生效。认股权证可在发行之日起的九十（90）天内以现金行使（除非双方延长）（“现金行使期”）。在现金行使期结束后的两周内，Streeterville Capital 将自动被视为进行了 “无现金” 行使，且公司将需向 Streeterville Capital 发行每十（10）股未行使认股权证股份对应的一（1）股普通股，无需额外对价。</p>
</div><p><strong>Summary of Amended Terms</strong></p>
<div class="lb-trans"><p><strong>修订条款摘要</strong></p>
</div><p>On December 16, 2025, EUDA and Streeterville Capital entered into the Warrant Amendment to (i) reduce the exercise price of the Warrant from US$6.00 per share to US$4.00 per share and (ii) reduce the minimum closing price required to trigger a “Forced Exercise” (defined in the Warrant) from US$7.50 to US$6.00. All other terms of the warrant remain unchanged.</p>
<div class="lb-trans"><p>2025 年 12 月 16 日，EUDA 与 Streeterville Capital 签署了认股权证修订，内容包括（i）将认股权证的行使价格从每股 6.00 美元降低至每股 4.00 美元，以及（ii）将触发 “强制行使”（在认股权证中定义）所需的最低收盘价从 7.50 美元降低至 6.00 美元。认股权证的其他条款保持不变。</p>
</div><p><strong>About EUDA Health Holdings Limited</strong></p>
<div class="lb-trans"><p><strong>关于 EUDA Health Holdings Limited</strong></p>
</div><p>EUDA Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based leading non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China. The Company aims to become a market leader in non-invasive and preventive healthcare, with a strategic focus on the fast-growing longevity sector. Our mission is to address the evolving healthcare needs of over 1.8 billion people across the region which is experiencing significant demographic shifts as more than 30% of the population ages rapidly. By offering innovative, accessible, and science-backed health solutions, EUDA is positioned to lead the transformation of regional healthcare from reactive medical treatment to proactive, longevity-focused care. EUDA also runs a Singapore-based property management business.</p>
<div class="lb-trans"><p>EUDA Health Holdings Limited（纳斯达克代码：EUDA）是一家总部位于新加坡的领先非侵入性医疗服务提供商，专注于新加坡、马来西亚和中国。公司旨在成为非侵入性和预防性医疗领域的市场领导者，战略重点放在快速增长的长寿产业。我们的使命是满足超过 18 亿人不断变化的医疗需求，该地区正经历显著的人口结构变化，超过 30% 的人口迅速老龄化。通过提供创新、可及且基于科学的健康解决方案，EUDA 致力于引领区域医疗从反应性医疗转向以长寿为重点的主动护理。EUDA 还经营一家总部位于新加坡的物业管理业务。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This document may contain forward-looking statements regarding risks and uncertainties. These statements usually use forward-looking words, such as the words “estimates,” “projected,” “expects,” “envisions,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions). These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside EUDA’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. You should not overly rely on forward-looking statements that are only applicable to the date of publication of this document. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.</p>
<div class="lb-trans"><p>本文件可能包含关于风险和不确定性的前瞻性声明。这些声明通常使用前瞻性词汇，例如 “估计”、“预测”、“期望”、“设想”、“预期”、“预测”、“计划”、“打算”、“相信”、“寻求”、“可能”、“将”、“应该”、“未来”、“提议” 及这些词或类似表达的变体（或这些词或表达的否定版本）。这些前瞻性声明并不保证未来的表现、状况或结果，并涉及许多已知和未知的风险、不确定性、假设和其他重要因素，其中许多超出了 EUDA 的控制范围，可能导致实际结果或结果与前瞻性声明中讨论的内容有实质性差异。您不应过于依赖仅适用于本文件发布之日的前瞻性声明。公司不承担更新或修订任何前瞻性声明的义务，无论是由于新信息、未来事件还是其他原因，法律要求的情况除外。</p>
</div><p>Christensen Advisory</p>
<div class="lb-trans"><p>Christensen Advisory</p>
</div><p>Christian Arnell</p>
<div class="lb-trans"><p>Christian Arnell</p>
</div><p>Phone: + 852 9040 0621</p>
<div class="lb-trans"><p>电话：+ 852 9040 0621</p>
</div><p>Email: christian.arnell@christensencomms.com</p>
<div class="lb-trans"><p>电子邮件：christian.arnell@christensencomms.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeU1UTXhNU00zTXpRNE5UVTRJelV3TURFeU5EUXpPUT09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTYyMTMxMSM3MzQ4NTU4IzUwMDEyNDQzOQ=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/Y2Y1ZDZkMDMtZTM0Yy00YzhmLTgzZDQtODYwMmRjMTA5MTVlLTUwMDEyNDQzOS0yMDI2LTAxLTA3LWVu/tiny/EUDA-Health-Holdings-Ltd.png" alt="" original-src="https://ml.globenewswire.com/media/Y2Y1ZDZkMDMtZTM0Yy00YzhmLTgzZDQtODYwMmRjMTA5MTVlLTUwMDEyNDQzOS0yMDI2LTAxLTA3LWVu/tiny/EUDA-Health-Holdings-Ltd.png"/></p>

Euda Health Holdings Limited 宣布修订 Streeterville 认股权协议 | Euda 股票新闻